Semaglutide for the Treatment of Obesity in Children 6 to <12 Years of Age
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
CONCLUSIONS: Among children (6 to <12 years of age) with obesity, treatment with semaglutide for 68 weeks resulted in a significantly greater mean percent reduction in BMI than placebo.
Appeared: Wednesday, November 18. New England Journal of Medicine. Peer-reviewed journal.